Prevalence and predictors of transitions to and away from syringe exchange use over time in 3 US cities with varied syringe dispensing policies

Drug and Alcohol Dependence

Volumn 111, Issue 1-2, 2010, Pages 74-81

  Green, Traci C ^a   Bluthenthal, Ricky N ^b   Singer, Merrill ^c   Beletsky, Leo ^a   Grau, Lauretta E ^a   Marshall, Patricia ^d   Heimer, Robert ^a  

^a YALE UNIVERSITY   (United States)

^b CALIFORNIA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF CONNECTICUT   (United States)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

HIV AIDS; Injecting drug use; Latent transition analysis; Longitudinal study; Syringe exchange

Indexed keywords

COCAINE; DIAMORPHINE;

ADULT; ARTICLE; BIOTYPOLOGY; DRUG ABUSE PATTERN; ETHNICITY; FEMALE; HEALTH CARE POLICY; HOMELESSNESS; HUMAN; INTRAVENOUS DRUG ABUSE; LEGAL LIABILITY; MALE; PREVALENCE; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; PROBABILITY; QUANTITATIVE ANALYSIS; SEX DIFFERENCE;

ADULT; CITIES; FEMALE; HIV INFECTIONS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEEDLE SHARING; NEEDLE-EXCHANGE PROGRAMS; ODDS RATIO; PREVALENCE; PUBLIC POLICY; REGRESSION ANALYSIS; SUBSTANCE ABUSE, INTRAVENOUS; UNITED STATES;

EID: 77956184559     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2010.03.022     Document Type: Article

References (46)

1. Bastos F.I., Strathdee S.A. Evaluating effectiveness of syringe exchange programmes: current issues and future prospects. Social Science & Medicine 2000, 51(12):1771-1782.
2. Beletsky, L., Heimer, R., Grau, L.E., 2009. Police-Public Health Collaboration in HIV Prevention: A Needs-Assessment Survey. AIDS Science Day, Yale Center for Interdisciplinary Research on AIDS, New Haven, CT.
3. Beletsky L., Macalino G.E., Burris S. Attitudes of police officers towards syringe access, occupational needle-sticks, and drug use: a qualitative study of One City Police Department in the United States. International Journal of Drug Policy 2005, 16:267-274.
4. Beyer L., Crofts N., Reid G. Drug offending and criminal justice responses: practitioners' perspectives. The International Journal on Drug Policy 2002, 13:199-207.
5. Bluthenthal R.N., Anderson R., Flynn N.M., Kral A.H. Higher syringe coverage is associated with lower odds of HIV risk and does not increase unsafe syringe disposal among syringe exchange program clients. Drug and Alcohol Dependence 2007, 89:214-222.
6. Bluthenthal R.N., Kral A.H., Gee L., Erringer E.A., Edlin B.R. The effect of syringe exchange use on high-risk injection drug users: a cohort study. AIDS (London, England) 2000, 14:605-611.
7. Bluthenthal R.N., Kral A.H., Lorvick J., Watters J.K. Impact of law enforcement on syringe exchange programs: a look at Oakland and San Francisco. Medical Anthropology 1997, 18:61-83.
8. Bluthenthal R.N., Malik M.R., Grau L.E., Singer M., Marshall P., Heimer R. Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities. Addiction (Abingdon, England) 2004, 99:1136-1146.
9. Bluthenthal R.N., Ridgeway G., Schell T., Anderson R., Flynn N.M., Kral A.H. Examination of the association between syringe exchange program (SEP) dispensation policy and SEP client-level syringe coverage among injection drug users. Addiction (Abingdon, England) 2007, 102:638-646.
10. Bluthenthal R.N., Watters J.K. Multimethod research: from targeted sampling to HIV risk behaviors. Qualitative Methods in the Prevention of Drug Abuse 1995, 212-230. National Institute on Drug Abuse, Rockville, MD. E.Y. Lambert, R.S. Ashery, R.H. Needle (Eds.).
11. Bourgois P. The moral economies of homeless heroin addicts: confronting ethnography, HIV risk, and everyday violence in San Francisco shooting encampments. Substance Use & Misuse 1998, 33:2323-2351.
12. Bryant J., Hopwood M. Secondary exchange of sterile injecting equipment in a high distribution environment: a mixed method analysis in south east Sydney, Australia. International Journal of Drug Policy 2009, 20:324-328.
13. Centers for Disease Control and Prevention, 2009. HIV/AIDS Surveillance Report, 2007, vol. 19. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta.
14. Chaisson R.E., Moss A.R., Onishi R., Osmond D., Carlson J.R. Human immunodeficiency virus infection in heterosexual intravenous drug users in San Francisco. American Journal of Public Health 1987, 77:169-172.
15. Clatts M.C., Sotheran J.L., Luciano P.A., Gallo T.M., Kochems L.M. The impact of drug paraphernalia laws on HIV risk among persons who inject illegal drugs: implications for public policy. How to Legalize Drugs 1998, 90-101. Jason Aronson, Northvale, NJ. J.M. Fish (Ed.).
16. Davis C.S., Burris S., Kraut-Becher J., Lynch K.G., Metzger D. Effects of an intensive street-level police intervention on syringe exchange program use in Philadelphia, PA. American Journal of Public Health 2005, 95:233-236.
17. De P., Cox J., Boivin J.-F., Platt R., Jolly A. Social network-related risk factors for bloodborne virus infections among injection drug users receiving syringes through secondary exchange. Journal of Urban Health 2008, 85:77-89.
18. DeBeck K., Wood E., Zhang R., Tyndall M., Montaner J., Kerr T. Police and public health partnerships: evidence from the evaluation of Vancouver's supervised injection facility. Substance Abuse Treatment, Prevention, and Policy 2008, 3:11.
19. Des Jarlais D.C., Marmor M., Paone D., Titus S., Shi Q., Perlis T., Jose B., Friedman S.R. HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet 1996, 348:987-991.
20. Grau L.E., Bluthenthal R.N., Marshall P., Singer M., Heimer R. Psychosocial and behavioral differences among drug injectors who use and do not use syringe exchange programs. AIDS and Behavior 2005, 9:495-504.
21. Green, T.C., Smith-Rohrberg, D., Allen, N., Heimer, R., Grau, L.E., 2006. Exploring the diffusion of benefit of syringe exchange programs in a cohort of injecting drug users: changes in injecting behaviors and injecting-related morbidity. Summer Institute in Longitudinal Research, Center for Advancing Longitudinal Drug Abuse Research, UCLA, Los Angeles, CA.
22. Grund J.P., Stern L.S., Kaplan C.D., Adriaans N.F., Drucker E. Drug use contexts and HIV-consequences: the effect of drug policy on patterns of everyday drug use in Rotterdam and the Bronx. British Journal of Addiction 1992, 87:381-392.
23. Hankins C., Alary M., Parent R., Blanchette C., Claessens C. Continuing HIV transmission among injection drug users in Eastern Central Canada: the SurvUDI Study, 1995 to 2000. Journal of Acquired Immune Deficiency Syndromes 2002, 30(5):514-521.
24. Heimer R. Community coverage and HIV prevention: assessing metrics for estimating HIV incidence through syringe exchange. The International Journal on Drug Policy 2008, 19(Suppl. 1):S65-S73.
25. Heimer R., Bluthenthal R.N., Singer M., Khoshnood K. Structural impediments to operational syringe-exchange programs. AIDS & Public Policy Journal 1996, 11:169-184.
26. Heimer R., Clair S., Grau L.E., Bluthenthal R.N., Marshall P.A., Singer M. Hepatitis-associated knowledge is low and risks are high among HIV-aware injection drug users in three US cities. Addiction (Abingdon, England) 2002, 97:1277-1287.
27. Heimer R., Clair S., Teng W., Grau L.E., Khoshnood K., Singer M. Effects of increasing syringe availability on syringe-exchange use and HIV risk: Connecticut, 1990-2001. Journal of Urban Health 2002, 79:556-570.
28. Heimer R., Khoshnood K., Bigg D., Guydish J., Junge J. Syringe use and re-use: effects of syringe exchange programs in four cities. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology 1998, 18(Suppl. 1):S37-44.
29. Heinzerling K.G., Kral A.H., Flynn N.M., Anderson R.L., Scott A., Gilbert M.L., Asch S.M., Bluthenthal R.N. Human immunodeficiency virus and hepatitis C virus testing services at syringe exchange programs: availability and outcomes. Journal of Substance Abuse Treatment 2007, 32:423-429.
30. Huo D., Bailey S.L., Hershow R.C., Ouellet L. Drug use and HIV risk practices of secondary and primary needle exchange users. AIDS Education and Prevention: Official Publication of the International Society for AIDS Education 2005, 17:170-184.
31. Koester S.K. Copping, running, and paraphernalia laws: contextual and needle risk behavior among injection drug users in denver. Human Organization 1994, 53:287-295.
32. Kral A.H., Anderson R., Flynn N.M., Bluthenthal R.N. Injection risk behaviors among clients of syringe exchange programs with different syringe dispensation policies. Journal of Acquired Immune Deficiency Syndromes 2004, 37(1999):1307-1312.
33. Lanza S.T., Collins L.M. A new SAS procedure for latent transition analysis: transitions in dating and sexual risk behavior. Developmental Psychology 2008, 44:446-456.
34. Lorvick J., Bluthenthal R.N., Scott A., Gilbert M.L., Riehman K.S., Anderson R.L., Flynn N.M., Kral A.H. Secondary syringe exchange among users of 23 California syringe exchange programs. Substance Use & Misuse 2006, 41:865-882.
35. Marmor M., Des Jarlais D.C., Cohen H., Friedman S.R., Beatrice S.T., Dubin N., el-Sadr W., Mildvan D., Yancovitz S., Mathur U., et al. Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City. AIDS (London, England) 1987, 1:39-44.
36. Martinez A.N., Bluthenthal R.N., Lorvick J., Anderson R., Flynn N., Kral A.H. The impact of legalizing syringe exchange programs on arrests among injection drug users in California. Journal of Urban Health 2007, 84:423-435.
37. Muthen L.K., Muthen B. Mplus User's Guide 2007, Muthen & Muthen, Los Angeles.
38. Schoenbaum E.E., Hartel D., Selwyn P.A., Klein R.S., Davenny K., Rogers M., Feiner C., Friedland G. Risk factors for human immunodeficiency virus infection in intravenous drug users. The New England Journal of Medicine 1989, 321:874-879.
39. Sears C., Guydish J.R., Weltzien E.K., Lum P.J. Investigation of a secondary syringe exchange program for homeless young adult injection drug users in San Francisco, California, U. S. A. JAIDS Journal of Acquired Immune Deficiency Syndromes 2001, 27:193-201.
40. Shutz C., Rapiti E., Vlahov D., Anthony J. Suspected determinants of enrollment into detoxification and methadone treatment among injecting drug users. Drug and Alcohol Dependence 1994, 36:129-138.
41. Singer M., Irizarry R., Schensul J.J. Needle access as an AIDS prevention strategy for IV drug users: a research perspective. Human Organization 1991, 50:142-153.
42. Singer M., Weeks M.R. Hartford Targeted Sampling Plan 1992, Community Alliance for AIDS Programs, Hartford, CT.
43. Strathdee S.A., Celentano D.D., Shah N., Lyles C., Stambolis V.A., Macalino G., Nelson K., Vlahov D. Needle-exchange attendance and health care utilization promote entry into detoxification. Journal of Urban Health 1999, 76:448-460.
44. Valente T.W., Foreman R.K., Junge B., Vlahov D. Satellite exchange in the Baltimore Needle Exchange Program. Public Health Reports 1998, 113(Suppl. 1):90-96.
45. Vlahov D., Junge B., Brookmeyer R., Cohn S., Riley E., Armenian H., Beilenson P. Reductions in high-risk drug use behaviors among participants in the Baltimore needle exchange program. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1997, 16(5):400-406.
46. Weatherburn D., Lind B. Street-level drug law enforcement and entry into methadone maintenance treatment. Addiction (Abingdon, England) 2001, 96:577-587.